Vitamin D Receptor Polymorphisms and Non-Melanoma Skin Cancer Risk

Completed

Conditions studied: Skin Cancer, Non-Melanoma

In brief

The purpose of this study is to discover whether certain Vitamin D Receptor (VDR) gene polymorphisms are associated with an increased risk of cutaneous basal cell carcinoma (BCC) and/or cutaneous squamous cell carcinoma (SCC) in an Alabama population. Participant demographic information such as physical characteristics (e.g., ethnicity), family history, and cancer diagnosis will be collected in order to determine if there are relationships between the gene polymorphisms, cancer diagnosis, and these characteristics.

Key facts

Study ID

NCT03040492

Run by

University of Alabama at Birmingham

People needed

200

Starts

2012-10-31

Expected to finish

2017-06-30

Last updated by the study team

2025-09-08

Who can join

Age: 50 and older. Sex: any. Healthy volunteers: accepted.

You may qualify if…

• Patients with non-melanoma skin cancer (cases)
• Patients without non-melanoma skin cancer or history of non-melanoma skin cancer (controls)
• Age 50 and older
• Native English speakers
• Patients at Kirklin Clinic

You may not qualify if…

• Age less than 50
• Diagnosis of melanoma or other type of cancer
• Non-English speakers

Where it is running

• The Kirklin Clinic — Birmingham, Alabama, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.